Am J Surg Pathol
- CHIEN YW, Wang Y, Huang P, Lawson BC, et al
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor
Lesions.
Am J Surg Pathol. 2024;48:475-486.
BMC Cancer
- HE D, Zhang X, Chang Z, Liu Z, et al
Survival time prediction in patients with high-grade serous ovarian cancer based
on (18)F-FDG PET/CT- derived inter-tumor heterogeneity metrics.
BMC Cancer. 2024;24:337.
- NIE X, Gao L, Zheng M, Wang S, et al
ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian
cancer.
BMC Cancer. 2024;24:330.
Cancer Lett
- KAUR P, Shankar E, Gupta S
EZH2-mediated development of therapeutic resistance in cancer.
Cancer Lett. 2024;586:216706.
Cancer Res
- RAMANARAYANAN V, Oberdoerffer P
AKTing on R Loops Makes for an ATRactive Target in Ovarian Cancer Therapy.
Cancer Res. 2024;84:793-795.
Eur J Obstet Gynecol Reprod Biol
- RODOLAKIS I, Liontos M, Pergialiotis V, Haidopoulos D, et al
Chemotherapy response score as a predictor of survival in ovarian cancer
patients.
Eur J Obstet Gynecol Reprod Biol. 2024;296:233-238.
- SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
Therapeutic management of uterine tumours resembling ovarian sex cord tumours
including a focus on fertility: A systematic review.
Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
PLoS One
- MIKHAEL S, Kurdi A, Khoueiry-Zgheib N, Tahtouh R, et al
Evaluating synergistic effects of metformin and simvastatin on ovarian cancer
cells.
PLoS One. 2024;19:e0298127.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016